MORPHINE SULFATE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of MORPHINE SULFATE INJECTION under NSN 6505014830274 and NDC 00641-6127-25. The delivery order, identified as SPE2DP-26-F-7903, has a total value of $85.98 for two packages at a unit price of $42.99 per package, with zero variance permitted in quantity. Delivery is scheduled for July 21, 2026, to the destination location at Rose Barracks, Vilseck, Germany, with FOB destination terms and the contractor responsible for all freight and delivery costs. The item is subject to government inspection and acceptance at the point of delivery, with no specified alternative inspection criteria beyond conformance to the contract terms. The awardee is certified as a Women-Owned Small Business and a Small Business, triggering compliance with FAR 19.7 and FAR 19.15 reporting obligations. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using the appropriation code 97X4930 5CBX 001 2620 S33189. The contracting officer is Lisa Quinn, and the issuing office is DLA Troop Support in Philadelphia, Pennsylvania. Packaging and marking requirements mandate that all shipments carry the identification numbers from Blocks 1 and 2 of the order and reference the tracking identifier W81X9C62020123, though no specific MIL-STDs, preservation methods, or labeling standards are detailed. No FAR or DFARS clauses are listed in the document, and there is no indication of special requirements, option periods, or evaluation factors beyond the determination that the award was made on a Lowest Price Technically Acceptable basis based on pre-established technical acceptability under the base contract. No attachments or formal inspection standards beyond contractual compliance are referenced, and the transaction represents a simplified acquisition with no modification or amendment numbers issued.